|
Jun 18
|
FDA approves Merck's pneumonia vaccine for adults
|
|
Jun 18
|
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
|
|
Jun 18
|
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
|
|
Jun 18
|
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
|
|
Jun 18
|
Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness
|
|
Jun 17
|
U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
|
|
Jun 17
|
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
|
|
Jun 13
|
Is Merck & Co. Inc. (NYSE:MRK) The Best Healthcare Stock to Buy in 2024?
|
|
Jun 13
|
Dividend stocks can help lower your risk. Many are bargains right now.
|
|
Jun 12
|
Women in Science? At Merck, Absolutely
|
|
Jun 11
|
A Hudson Valley Estate Set on 53 Hilltop Acres Is Listing for $12.25 Million
|
|
Jun 11
|
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
|
|
Jun 11
|
Here’s Why Merck & Co. (MRK) Shares Closed Strongly in Q1
|
|
Jun 9
|
Investors more bullish on Merck (NYSE:MRK) this week as stock climbs 4.1%, despite earnings trending downwards over past three years
|
|
Jun 7
|
The City With the highest HIV/AIDS Rates in the US
|
|
Jun 6
|
How Merck Scientists Are Driving Next-Generation Cancer Research
|
|
May 25
|
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
|
|
May 23
|
ASCO24: An early look at cancer drug study results
|
|
May 22
|
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
|
|
May 20
|
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
|